It should be noted, however, that despite the established role of CCL2 in developmental and tumor-associated lymphangiogenesis [105], the exact molecular mechanism linking CCL2 activation with the enhanced VEGF-C expression remains to be elucidated. The gene discussed is VEGFC; the disease is neoplasm.